Polydatin Reverses Diabetes‐Induced Apoptosis of Pancreatic β ‐Cells by Inhibiting the TNF/TNF‐R1/Caspase‐3 Signaling Axis
Journal of Diabetes Research · 2026
DOI: 10.1155/jdr/9073132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2026. Verfasst von Jun Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Chinese Medicines, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn. Hauptthemen laut MEDLINE: Insulin-Secreting Cells, Stilbenes, Apoptosis, Tumor Necrosis Factor-alpha. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Graduate Education Innovation Projects of Guizhou University of Traditional Chinese Medicine, Guizhou Provincial Department of Education Youth Science and Technology Talents Growth Project, Guizhou Provincial Basic Research Program (General Program).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Pancreatic β ‐apoptosis is a critical pathological event in diabetes mellitus (DM), yet effective therapeutic agents that directly protect β ‐cells are lacking. Polydatin (PD), a natural stilbenoid, has shown potential in regulating glucolipid metabolism; however, its role and mechanism in protecting pancreatic β ‐cells from apoptosis remain largely unexplored.
Objective
The present work focused on investigating whether PD prevents pancreatic β ‐cells against diabetes‐related apoptosis and exploring the associated molecular mechanisms, with a particular focus on the TNF/TNF‐R1/caspase‐3 signaling axis.
Methods
Network pharmacology and bioinformatics were applied in combination with experimental validation. Potential targets of PD and DM were retrieved from public databases. Key candidate targets were screened via protein–protein interaction (PPI) analysis, least absolute shrinkage and selection operator (LASSO) regression, functional enrichment (GO/KEGG), differential expression, receiver operating characteristic (ROC), and clinical correlation analyses. Binding interactions were assessed by molecular docking alongside dynamic simulations. In vitro and in vivo DM models were established with high glucose (HG)–stimulated MIN6 β ‐cells and high‐fat/HG diet‐fed mice with low‐dose streptozotocin (STZ) administration, respectively.
Results
TNF was identified as a central target of PD against DM, with elevated expression under diabetic conditions and a significant correlation with fasting blood glucose levels. PD exhibited strong binding affinity to both TNF (Vina score: –8.9 kcal·mol −1 ) and TNF‐R1 (Vina score: –8.8 kcal·mol −1 ). Cellular experiments demonstrated that PD enhanced β ‐cell cycle progression (upregulated Ki67 expression), downregulated TNF‐R1 expression, and facilitated insulin secretion under HG stimulation. In diabetic mice, PD significantly increased the islet β ‐cell mass and area; downregulated the expression of TNF, TNF‐R1, and cleaved‐caspase‐3; and restored PARP1 expression.
Conclusion
This study revealed that PD attenuated diabetic β ‐apoptosis, likely through inhibition of the TNF/TNF‐R1/caspase‐3 pathway, suggesting that PD may be a novel anti‐DM therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Basic Chinese Medicines, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn.
- School of Pharmaceutical Sciences, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn.
- School of First Clinical Medical, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn.
- School of Basic Medicine, Guizhou University of Traditional Chinese Medicine, Guiyang, China, gzu.edu.cn.
ORCID-Profile: Jun Li, Xuetong Wu, Nannan Zhang
Förderung
- Graduate Education Innovation Projects of Guizhou University of Traditional Chinese Medicine
- Guizhou Provincial Department of Education Youth Science and Technology Talents Growth Project
- Guizhou Provincial Basic Research Program (General Program)
Zitieren
APA
Li, J., Zhou, Y., Wu, X., Cheng, G., Ma, Q., Zhou, Y., & Zhang, N. (2026). Polydatin Reverses Diabetes‐Induced Apoptosis of Pancreatic β ‐Cells by Inhibiting the TNF/TNF‐R1/Caspase‐3 Signaling Axis. Journal of Diabetes Research. https://doi.org/10.1155/jdr/9073132
Vancouver
Li J, Zhou Y, Wu X, Cheng G, Ma Q, Zhou Y, et al. Polydatin Reverses Diabetes‐Induced Apoptosis of Pancreatic β ‐Cells by Inhibiting the TNF/TNF‐R1/Caspase‐3 Signaling Axis. Journal of Diabetes Research. 2026. doi:10.1155/jdr/9073132
BibTeX
@article{Li2026,
author = {Li, Jun and Zhou, Yifan and Wu, Xuetong and Cheng, Guo and Ma, Qun and Zhou, Yixue and Zhang, Nannan},
title = {Polydatin Reverses Diabetes‐Induced Apoptosis of Pancreatic β ‐Cells by Inhibiting the TNF/TNF‐R1/Caspase‐3 Signaling Axis},
journal = {Journal of Diabetes Research},
year = {2026},
doi = {10.1155/jdr/9073132}
}
EUVIMED